Annual EBITDA
-$436.18 M
-$100.67 M-30.01%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual EBITDA is -$436.18 million, with the most recent change of -$100.67 million (-30.01%) on December 31, 2023.
- During the last 3 years, IBRX annual EBITDA has fallen by -$231.96 million (-113.58%).
- IBRX annual EBITDA is now -210.89% below its all-time high of -$140.30 million, reached on December 31, 2019.
Performance
IBRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$41.07 M
+$50.09 M+54.95%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly EBITDA is -$41.07 million, with the most recent change of +$50.09 million (+54.95%) on September 30, 2024.
- Over the past year, IBRX quarterly EBITDA has increased by +$50.09 million (+54.95%).
- IBRX quarterly EBITDA is now -28.10% below its all-time high of -$32.06 million, reached on March 31, 2020.
Performance
IBRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$421.03 M
+$15.02 M+3.44%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM EBITDA is -$421.03 million, with the most recent change of +$15.02 million (+3.44%) on September 30, 2024.
- Over the past year, IBRX TTM EBITDA has increased by +$15.02 million (+3.44%).
- IBRX TTM EBITDA is now -1213.29% below its all-time high of -$32.06 million, reached on March 31, 2020.
Performance
IBRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IBRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.0% | +55.0% | +3.4% |
| 3 y3 years | -113.6% | +59.5% | -21.1% |
| 5 y5 years | -210.9% | +59.5% | -21.1% |
IBRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.0% | at low | at high | +79.1% | -34.1% | +5.6% |
| 5 y | 5-year | -210.9% | at low | -28.1% | +79.1% | -1213.3% | +5.6% |
| alltime | all time | -210.9% | at low | -28.1% | +79.1% | -1213.3% | +5.6% |
ImmunityBio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$41.07 M(-55.0%) | -$421.03 M(-3.4%) |
| Jun 2024 | - | -$91.16 M(-1.0%) | -$436.05 M(-2.3%) |
| Mar 2024 | - | -$92.09 M(-53.2%) | -$446.18 M(+2.3%) |
| Dec 2023 | -$436.18 M(+30.0%) | -$196.72 M(+250.8%) | -$436.18 M(+38.9%) |
| Sep 2023 | - | -$56.08 M(-44.6%) | -$313.97 M(-9.7%) |
| Jun 2023 | - | -$101.30 M(+23.4%) | -$347.78 M(+6.3%) |
| Mar 2023 | - | -$82.09 M(+10.2%) | -$327.18 M(-2.5%) |
| Dec 2022 | -$335.51 M | -$74.50 M(-17.1%) | -$335.53 M(-2.6%) |
| Sep 2022 | - | -$89.90 M(+11.4%) | -$344.49 M(+2.6%) |
| Jun 2022 | - | -$80.69 M(-10.8%) | -$335.73 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$90.44 M(+8.4%) | -$336.85 M(+5.0%) |
| Dec 2021 | -$320.75 M(+57.1%) | -$83.47 M(+2.9%) | -$320.75 M(+6.6%) |
| Sep 2021 | - | -$81.13 M(-0.8%) | -$301.00 M(+6.8%) |
| Jun 2021 | - | -$81.82 M(+10.1%) | -$281.97 M(+14.4%) |
| Mar 2021 | - | -$74.33 M(+16.7%) | -$246.50 M(+20.7%) |
| Dec 2020 | -$204.22 M(+45.6%) | -$63.72 M(+2.6%) | -$204.22 M(+45.4%) |
| Sep 2020 | - | -$62.09 M(+34.0%) | -$140.50 M(+79.2%) |
| Jun 2020 | - | -$46.35 M(+44.6%) | -$78.41 M(+144.6%) |
| Mar 2020 | - | -$32.06 M | -$32.06 M |
| Dec 2019 | -$140.30 M | - | - |
FAQ
- What is ImmunityBio annual EBITDA?
- What is the all time high annual EBITDA for ImmunityBio?
- What is ImmunityBio annual EBITDA year-on-year change?
- What is ImmunityBio quarterly EBITDA?
- What is the all time high quarterly EBITDA for ImmunityBio?
- What is ImmunityBio quarterly EBITDA year-on-year change?
- What is ImmunityBio TTM EBITDA?
- What is the all time high TTM EBITDA for ImmunityBio?
- What is ImmunityBio TTM EBITDA year-on-year change?
What is ImmunityBio annual EBITDA?
The current annual EBITDA of IBRX is -$436.18 M
What is the all time high annual EBITDA for ImmunityBio?
ImmunityBio all-time high annual EBITDA is -$140.30 M
What is ImmunityBio annual EBITDA year-on-year change?
Over the past year, IBRX annual EBITDA has changed by -$100.67 M (-30.01%)
What is ImmunityBio quarterly EBITDA?
The current quarterly EBITDA of IBRX is -$41.07 M
What is the all time high quarterly EBITDA for ImmunityBio?
ImmunityBio all-time high quarterly EBITDA is -$32.06 M
What is ImmunityBio quarterly EBITDA year-on-year change?
Over the past year, IBRX quarterly EBITDA has changed by +$50.09 M (+54.95%)
What is ImmunityBio TTM EBITDA?
The current TTM EBITDA of IBRX is -$421.03 M
What is the all time high TTM EBITDA for ImmunityBio?
ImmunityBio all-time high TTM EBITDA is -$32.06 M
What is ImmunityBio TTM EBITDA year-on-year change?
Over the past year, IBRX TTM EBITDA has changed by +$15.02 M (+3.44%)